Athira Pharma Posts GAAP EPS of -$24.70 Athira Pharma reported GAAP EPS of -$24.70 on Mar 27, 2026; investors should await the 10-Q to parse non-cash items, cash runway and financing needs.

Athira Pharma Posts GAAP EPS of -$24.70: Athira Pharma reported GAAP EPS of -$24.70 on Mar 27, 2026; investors should await the 10-Q to parse non-cash items, cash runway and financing needs. 👈 Read full analysis #AthiraPharma #GAAPEPS #Investing #FinanceNews #StockMarket